A new NIH-funded UAB trial will test adaptive protocols for preserving muscle during weight loss, offering clear insights for executive health and longevity.
On September 11, 2026, the University of Alabama at Birmingham announced a five-year, $3.7 million NIH-funded study. The research will examine how to achieve clinically meaningful weight loss while preserving skeletal-muscle mass and strength. Led by Drew Sayer, Ph.D., the trial focuses on adults aged 50 to 75 with obesity. The primary objective is to avoid the rapid decline in physical strength often associated with intensive weight reduction.
Sayer operates as an assistant professor in the UAB Department of Family and Community Medicine. Tapan Mehta, Ph.D., will serve as a key collaborator alongside Adele Fowler and the designated research team. The formal project title is “Optimizing adaptive intensive behavioral therapy for obesity during the transition to older adulthood.” This focus on the transition into older age makes the upcoming findings highly relevant for midlife professionals.
The UAB researchers utilize a Sequential Multiple Assignment Randomized Trial design. This structure allows researchers to adapt treatments after an interim assessment rather than forcing one fixed intervention. Initially, participants are randomized to one of two calorie-restricted diets. These starting diets include either a high-protein plan or a standard-protein approach.
After eight weeks, researchers will formally assess participant progress and biological response. Participants who are not responding optimally will be randomized to either targeted protein supplementation or supervised resistance-training sessions. Every participant will also receive 16 weeks of intensive weekly group behavioral sessions. These initial behavioral interventions are followed by nine months of monthly maintenance meetings.
The behavioral framework relies on a weight-management program called State of Slim. This established program was developed by Holly Wyatt and James Hill. Both doctors serve as longtime collaborators and trusted mentors to the UAB research team. The study will conduct physical assessments at the UAB Wellness, Health And Research Facility.
Additional institutional support comes from the Metabolism Core and Behavioral and Clinical Interventions Core. The adaptive design better reflects the reality of clinical practice where patients respond differently to identical starting conditions. Researchers ultimately want to identify which specific sequence of diet and training maximizes weight loss while limiting lean tissue loss. They will rigorously assess muscle protein synthesis, cardiometabolic health, and activities of daily living.
Founders and operators frequently pursue weight loss to support metabolic health. However, successful weight reduction must prioritize sustained physical capacity over short-term scale changes. Leaders using anti-obesity medications must pay close attention to how their bodies actually change. Relying solely on a basic bathroom scale can mask the hidden cost of declining functional strength.
A practical executive health program demands a comprehensive performance scorecard. This comprehensive scorecard should track body weight, waist circumference, physical function, and relevant metabolic markers. When executives face intense demands, perfect theoretical regimens routinely fail under pressure. In our experience, theoretical regimens routinely fail when confronted with actual executive travel schedules.
Our team learned this firsthand: "I remember landing at Heathrow after a brutal overnight flight from New York. I had a board meeting in three hours. The standard advice of getting eight hours of sleep felt like a cruel joke."
The realization was immediate. "That was the exact moment I realized our readers do not need perfect scenarios. They need triage protocols. They need to know what the science says about recovering cognitive function when you only managed three hours of terrible sleep at high altitude."
This same fundamental triage principle applies directly to midlife metabolic health and weight management. Demanding professionals need adaptive systems that escalate support when initial methods inevitably fall short. Program designers should therefore treat resistance training as a core intervention rather than an optional addition. Maintaining physical independence is essential for long-term executive longevity.
The regional rationale for the UAB trial provides clear context for the research urgency. UAB notes that nearly 39 percent of Alabama adults currently have obesity. Furthermore, 43.6 percent of adults aged 45 to 64 in the state have obesity. More than one-third of the total Alabama population falls into the targeted 50 to 75 age bracket.
Muscle preservation is gaining immense attention as more people utilize modern obesity treatments. A recent review examined skeletal-muscle changes during GLP-1 receptor agonist treatment. The review found that skeletal muscle accounted for approximately 8.5 percent to 24.5 percent of total weight loss. However, many studies also showed that muscle quality often improved through greater density and reduced fat infiltration.
Resistance training alongside these therapies remains the clinical standard for mitigating lean-mass loss. Calorie restriction and resistance training also impact body composition in distinct ways. A meta-analysis of older adults found clear benefits when combining protein supplementation with resistance exercise. This specific combination produced a standardized mean difference of 0.58 for lean mass gains.
It also resulted in a 0.69 standardized mean difference for leg strength improvements compared to resistance training alone. Another systematic review showed that higher protein intake attenuated lean-mass loss by 0.36 kilograms during energy restriction. Current maintenance-oriented recommendations cite daily protein intakes of approximately 1.2 to 1.6 grams per kilogram of body weight.
The UAB announcement outlines a planned trial rather than completed, published research. No participant results are currently available to confirm which specific pathway works best. The adaptive study design promises highly useful clinical information for future applications. However, this structure makes interpretation complex because outcomes rely on multiple phased variables.
The public announcement deliberately omits the planned sample size, exact protein targets, and specific calorie deficits. Muscle quantity and functional capacity are definitively not identical metrics. Changes in hydration and glycogen can significantly distort estimates of fat-free mass during rapid weight loss. This reality makes the trial's planned assessment of actual physical strength and daily function crucial.
The findings will eventually help clarify the critical difference between raw scale weight and genuine physical capability. The broader literature remains encouraging but highly heterogeneous across different ages and health statuses. Furthermore, higher protein intake is not automatically appropriate or safe for every individual. Kidney disease, specific medication use, dietary preferences, and gastrointestinal tolerance can heavily complicate high-protein prescriptions.
The UAB trial utilizes supervised resistance training to ensure rigorous protocol adherence. This tightly structured environment does not guarantee that independent professionals can easily replicate the physical results. Real-world execution frequently requires dedicated clinical support to navigate scheduling challenges and injury risks.
The medical consensus is steadily moving toward preserving function rather than just reducing mass. An expert consensus on managing obesity in older adults heavily supports combining exercise with calorie restriction. This combined approach helps maintain essential muscle while improving insulin resistance and cardiometabolic risk factors. The consensus recommends resistance training two to three days per week with repeated sets.
Future clinical guidelines will likely integrate adaptive interventions that monitor strength as closely as total weight. The UAB trial represents a critical step toward precision behavioral therapy for midlife adults. As metabolic performance programs evolve, the primary focus will remain squarely on maintaining physical independence. Operators should anticipate a near future where standard medical metrics routinely include comprehensive lean tissue assessments.
The ultimate executive goal is preserving the foundational physical strength necessary to execute demanding professional roles. Achieving this requires building a reliable structural approach to sustainable performance rather than chasing rapid scale changes. Executives planning midlife weight loss now have a clear signal that the science of preserving lean mass is advancing rapidly.
Stay connected for research and practical guidance on executive performance, energy, focus, sleep, recovery and longevity. Ideas built for people who want to stay sharp, capable and effective for the long run.
Build habits and systems that support clear thinking, steady energy and long term capacity throughout a demanding career.
explore the Blog
